SA
Stewart Appelrouth
Director

Stewart Appelrouth insider trades: AIM ImmunoTech (AIM) stock purchases

Director, AIM ImmunoTech Last trade Dec 2, 2024 49 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2016
2
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Stewart reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 2, 2024AIM↑ Buy$2K
Nov 20, 2024AIM↑ Buy$16K
Mar 15, 2024AIM↑ Buy$30K
Jan 3, 2023AIM↑ Buy$25K
Feb 25, 2021AIM↑ Buy$25K
Jun 21, 2019HEB↑ Buy$39K
Nov 5, 2018HEB↑ Buy$6K
Jul 24, 2018HEB↑ Buy$39K
Apr 27, 2018HEB↑ Buy$32K
Aug 24, 2016HEB↑ Buy$35K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AIM insiders

Open-market trades in the last 12 months

About Stewart Appelrouth's insider trades

Stewart Appelrouth is a director at AIM ImmunoTech (AIM). Since Aug 24, 2016, Stewart has reported 10 open-market purchases worth $249K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (22 filings), other transactions (15 filings), conversions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AIM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.